SOPHiA GENETICS officer plans $46.9K stock sale

An officer of SOPHiA GENETICS SA filed a Rule 144 notice to resell 6,168 vested RSU shares with an indicated market value of $46,938.48.

Rhea-AI Filing Summary

SOPHiA GENETICS SA (SOPH) received a notice that Daan Guido Maria Van Well, an officer, intends to sell up to 6,168 shares of Common Stock under Rule 144 through Morgan Stanley Smith Barney LLC. The shares were acquired from the issuer upon vesting of restricted stock units on July 2 and July 3, 2026.

The notice lists an aggregate market value of $46,938.48 for the securities to be sold and identifies NASDAQ as the trading market. The RSUs were originally granted by the issuer and the planned sale is for the officer’s account.

Key Figures

Shares to be sold: 6,168 shares Aggregate market value of securities to be sold: $46,938.48 Shares outstanding (context): 85,127,825 shares +2 more

5 metrics

Shares to be sold 6,168 shares Common stock covered by the Rule 144 notice

Aggregate market value of securities to be sold $46,938.48 Value associated with 6,168 shares in the notice

Shares outstanding (context) 85,127,825 shares Figure listed alongside the securities information

Date of acquisition/vesting July 2, 2026 and July 3, 2026 RSU vesting dates for the shares to be sold

Date of notice September 11, 2026 Filing date of the Rule 144 notice

Key Terms

Rule 144, Restricted Stock Units, aggregate market value, securities to be sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"The securities to be sold were acquired upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

aggregate market value financial

"6168 | 46938.48 | 85127825 | 09/11/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

securities to be sold financial

"The securities to be sold were acquired upon the vesting of restricted stock units"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for SOPH?

It discloses that an officer, Daan Guido Maria Van Well, intends to sell up to 6,168 shares of SOPHiA GENETICS SA common stock under Rule 144, representing shares acquired from the issuer upon RSU vesting in July 2026.

How many SOPH shares are covered by this Form 144 notice?

The notice covers up to 6,168 shares of SOPHiA GENETICS SA common stock, corresponding to shares acquired upon vesting of restricted stock units on July 2, 2026 and July 3, 2026.

What is the market value of the SOPH shares in the planned Rule 144 sale?

The filing lists an aggregate market value of $46,938.48 for the 6,168 shares of SOPHiA GENETICS SA common stock covered by the planned Rule 144 sale.

How and where are the SOPH shares expected to be sold?

The shares are expected to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services with trading on NASDAQ, as indicated in the securities information section of the notice.

How were the SOPH shares in this Form 144 acquired?

According to the notice, the securities to be sold were acquired from the issuer upon the vesting of restricted stock units on July 2, 2026 and July 3, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 04:31 PM EDT Accepted by SEC EDGAR 09/11/2026 - 04:30 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002006414
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	DAAN GUIDO MARIA VAN WELL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6168	46938.48	85127825	09/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/02/2026	Restricted Stock Units	Issuer			6168	07/02/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units on 07/02/2026 and 07/03/2026.
Date of Notice	09/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daan Guido Maria Van Well
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)